LANSING, Mich., Aug. 29, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2024 Wells Fargo Healthcare Conference in Boston, Massachusetts, on Thursday, September 5.
David Naemura, Neogen's Chief Financial Officer, will present at 3:00 PM Eastern Time.
To access the webcast and presentation materials, please visit the Events & Presentations section of the Neogen Investor Relations website at neogen.com/investor-relations/events-presentations and click on the event webcast link.
About Neogen
Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.
Media Contact
Bill Waelke, Vice President, IR & Treasury
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$9.22 |
| Daily Change: | -0.26 -2.74 |
| Daily Volume: | 2,438,684 |
| Market Cap: | US$2.000B |
January 21, 2025 January 10, 2025 December 17, 2024 October 10, 2024 | |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
